Overall Survival Benefit with Tebentafusp in Metastatic Uveal MelanomaPaul Nathan, Sophie Piperno‐Neumann, Jessica C. Hassel et al.|New England Journal of Medicine|2021Cited by 869
European consensus-based interdisciplinary guideline for melanoma. Part 1: Diagnostics: Update 2022Claus Garbe, Paul Lorigan, D. Moreno‐Ramírez et al.|European Journal of Cancer|2022Cited by 320
European consensus-based interdisciplinary guideline for melanoma. Part 2: Treatment - Update 2022Claus Garbe, Paul Lorigan, Teresa Amaral et al.|European Journal of Cancer|2022Cited by 287
Selumetinib in Combination With Dacarbazine in Patients With Metastatic Uveal Melanoma: A Phase III, Multicenter, Randomized Trial (SUMIT)Richard D. Carvajal, Paul Nathan, Sophie Piperno‐Neumann et al.|Journal of Clinical Oncology|2018Cited by 274
ESMO consensus conference recommendations on the management of metastatic melanoma: under the auspices of the ESMO Guidelines CommitteeUlrich Keilholz, Olivier Michielin, P.A. Ascierto et al.|Annals of Oncology|2020Cited by 232